CIK 0000882095
- Large accelerated filer
GILEAD SCIENCES, INC.
Sign in to watch- Ticker
- GILD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943047598
- Phone
- +1 650-574-3000
- Business address
- 333 LAKESIDE DR, FOSTER CITY, CA, 94404
- Former names
- GILEAD SCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $36,996,096
- in 12 filings, $37.0M under 10b5-1 plans
Net −$36,996,096. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-06 | Mercier Johanna Chief Commercial Officer | Sale 10b5-1 | −5,000 | $91.28 | $456K | 73,127 |
| 2024-11-06 | Parsey Merdad Chief Medical Officer | Option exercise 10b5-1 | +25,000 | $57.92 | $1.4M | 125,189 |
| 2024-11-06 | Parsey Merdad Chief Medical Officer | Sale 10b5-1 | −20,590 | $91.50 | $1.9M | 104,599 |
| 2024-11-06 | Parsey Merdad Chief Medical Officer | Sale 10b5-1 | −5,000 | $91.50 | $458K | 99,599 |
| 2024-11-06 | Parsey Merdad Chief Medical Officer | Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 | −25,000 | 121,670 | ||
| 2024-10-25 | Telman Deborah H EVP, Corporate Affairs & GC | Option exercise | +514 | 21,221 | ||
| 2024-10-25 | Telman Deborah H EVP, Corporate Affairs & GC | Shares withheld for taxes | −242 | $89.00 | $22K | 20,979 |
| 2024-10-25 | Telman Deborah H EVP, Corporate Affairs & GC | Option exercise · Restricted Stock Unit | −514 | 29,033 | ||
| 2024-10-01 | Parsey Merdad Chief Medical Officer | Sale 10b5-1 | −2,000 | $83.83 | $168K | 100,189 |
| 2024-09-12 | Parsey Merdad Chief Medical Officer | Option exercise 10b5-1 | +25,000 | $57.92 | $1.4M | 123,435 |
| 2024-09-12 | Parsey Merdad Chief Medical Officer | Sale 10b5-1 | −21,246 | $84.50 | $1.8M | 102,189 |
| 2024-09-12 | Parsey Merdad Chief Medical Officer | Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 | −25,000 | 146,670 | ||
| 2024-09-12 | Mercier Johanna Chief Commercial Officer | Sale 10b5-1 | −15,925 | $84.23 | $1.3M | 91,559 |
| 2024-09-12 | Mercier Johanna Chief Commercial Officer | Sale 10b5-1 | −13,432 | $83.25 | $1.1M | 78,127 |
| 2024-09-10 | Telman Deborah H EVP, Corporate Affairs & GC | Option exercise | +639 | 21,014 | ||
| 2024-09-10 | Telman Deborah H EVP, Corporate Affairs & GC | Shares withheld for taxes | −307 | $81.44 | $25K | 20,707 |
| 2024-09-10 | Telman Deborah H EVP, Corporate Affairs & GC | Option exercise · Restricted Stock Unit | −639 | 29,547 | ||
| 2024-09-10 | Patterson Sandra SVP, Controllership | Option exercise | +901 | 36,877 | ||
| 2024-09-10 | Patterson Sandra SVP, Controllership | Shares withheld for taxes | −292 | $81.44 | $24K | 36,585 |
| 2024-09-10 | Patterson Sandra SVP, Controllership | Option exercise · Restricted Stock Unit | −901 | 13,183 |
Page 24 of 30 · 599 trades